Effects of S-nitroso-glutathione in the human forearm circulation: Evidence for selective inhibition of platelet activation

Cardiovascular Research

Volumn 28, Issue 5, 1994, Pages 691-694

  Belder, Adam J De ^a,b,c   Macallister, Raymond ^a,b,c   Radomski, Marek W ^a,b,c   Moncada, Salvador ^a,b,c   Vallance, Patrick J T ^a,b,c  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c WELLCOME RESEARCH LABORATORIES   (United Kingdom)

Author keywords

Blood flow; Nitric oxide; Platelets

Indexed keywords

ADENOSINE DIPHOSPHATE; NITRIC OXIDE; S NITROSOGLUTATHIONE;

ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DIABETES MELLITUS; HUMAN; HYPERTENSION; INTRAARTERIAL DRUG ADMINISTRATION; MALE; NORMAL HUMAN; PLETHYSMOGRAPHY; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; VASODILATATION;

ADENOSINE DIPHOSPHATE; ADULT; DEPRESSION, CHEMICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FOREARM; GLUTATHIONE; HUMAN; MALE; MIDDLE AGE; NITROSO COMPOUNDS; PLATELET ACTIVATION; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PLETHYSMOGRAPHY; REGIONAL BLOOD FLOW; S-NITROSOGLUTATHIONE; SUPPORT, NON-U.S. GOV'T; VASODILATION;

EID: 0028264373     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1093/cvr/28.5.691     Document Type: Article

References (24)

1. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide physiology, pathophysiology and pharmacology. Pharmacol Rev 1991;43: 109-42
2. Radomski MW, Palmer RMJ, Moncada S. An L-arginine/nitric oxide pathway present in human platelets regulates platelet aggregation. Proc Natl Acad Sci USA 1990;87:5193-7
3. G-monomethyl-L-argmine in patients with hypertension: the nitric oxide dilator mechanism appears abnormal. J Hypertens 1990;10:1025-31
4. Calver A, Collier J, Vallance P. Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. J Clin Invest 1992;90:2548-54
5. Drexler H, Zeiher AM, Meinzer K, Just H. Correction of endothelial dysfunction in coronary microcirculation of hyper-cholesterolaemic patients by L-arginine. Lancer 199l;338: 1546-50
6. Radomski MW, Moncada S. Regulation of platelet function by nitric oxide. Thromb Haemost Disord 1993;7:1-7
7. Ignarro LJ, Gruetter CA. Requirement of thiols for activation of coronary arterial guanylate cyclase by glyceryl trinitrate and sodium nitrite. Possible involvement of S-nitrosothiols. Biochem Biophys Acta 1980;631:221-31
8. Stamler JS, Singel DJ, Loscalzo J. Biochemistry of nitric oxide and its redox-activated forms. Science 1992;258:1898-902
9. Mellion BT, Ignarro LJ, Myers CB, et al. Inhibition of human platelet aggregation by S-nitrosothiols. Heme-dependent activation of soluble guanylate cyclase and stimulation of cyclic GMP accumulation. Mol Pharmacol 1983;23:653-64
10. Park JW. Reaction of S-nitroso-glutathione with sulfhydryl groups in protein. Biochem Biophys Res Commun 1988;152:916-20
11. Meister A, Anderson ME. Glutathione. Annu Rev Biochem 1983;52:71160
12. Radomski MW, Rees DD, Dutra A, Moncada S. S-nitroso-glutathione inhibits platelet activation in vitro and in vivo. Br J Pharmacol 1992;107:745-9
13. Whitney RJ. The measurement of volume change in human limbs. J Physiol (Lond) 1953;121:1-27
14. Gerzer R, Karrenbrock W, Seiss W, Heim J-H. Direct comparison of the effects of nitroprusside, SIN-1 and various nitrates on platelet aggregation and soluble guanylate cyclase activity. Thromb Res 1988;52:11-21
15. Mendelsohn ME, O’Neill S, George D, Loscalzo J. Inhibition of fibrinogen binding to human platelets by S-nitroso-N-acetyl-cysteine. J Biol Chem 1990;265:19028-34
16. Lieberman EH, O’Neill S, Mendelsohn M. S-nitrosocysteine inhibition of human platelet secretion is correlated with increases in platelet cGMP levels. Circ Res 1991;68:1722-8
17. Stamler JS, Simon DI, Osbourne JA, et al. S-nitrosylation of proteins with nitric oxide: synthesis and characterisation of biologically active compounds. Proc Natl Acad Sci USA 1992; 89:444-8
18. Keaney JF, Simon DI, Stamler JS, et al. NO forms an adduct with serum albumin that has endothelium-derived relaxing factor-like properties. J Clin Invest 1993;91:1582-9
19. Martin W, Villani GM, Jothianandan D, Furchgott RF. Selective blockade of endothelium-derived and glyceryl trinitrate-induced relaxation by haemoglobin and by methylene blue in the rabbit aorta. J Pharmacol Exp Ther 1985;232:708-16
20. Butler AR, Askew SC, Flitney FW, Megson I. The vasodilator action of S-nitrosoglutathione. Evidence for NO transfer. (Abstract) Endothelium 1993;1:S37
21. Ross R, Glomset JA, The pathogenesis of atherosclerosis (part I). N Engl J Med 1976;295:369-77
22. Ross R, Glomset JA. The pathogenesis of atherosclerosis (part II). N Engl J Med 1976;295:420-5
23. Davies MJ, Thomas AC, Knapman PA, Hanzertner JR. Intramyocardial platelet aggregation in patients with unstable anginasuffering sudden ischaemic cardiac death. Circulation 1986;76: 418-27
24. Scharf RE, Tomer A, Marzer UM, Teirstein PE, Ruggeri ZM, Harker LA. Activation of platelets in blood perfusing angioplasty damaged coronary arteries. Flow cytometric detection. Arteriosclerosis Thromb 1992;12:1475-87